AAAAAA

   
Results: 1-2 |
Results: 2
Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer
Authors: Batist, G Ramakrishnan, G Rao, CS Chandrasekharan, A Gutheil, J Guthrie, T Shah, P Khojasteh, A Nair, MK Hoelzer, K Tkaczuk, K Park, YC Lee, LW
Citation: G. Batist et al., Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer, J CL ONCOL, 19(5), 2001, pp. 1444-1454
Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptorantagonist
Authors: Navari, RM Reinhardt, RR Gralla, RJ Kris, MG Hesketh, PJ Khojasteh, A Kindler, H Grote, TH Pendergrass, K Grunberg, SM Carides, AD Gertz, BJ
Citation: Rm. Navari et al., Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptorantagonist, N ENG J MED, 340(3), 1999, pp. 190-195
Risultati: 1-2 |